1.2500
-0.1100
(-8.09%)
At close: January 10 at 4:00:00 PM EST
1.2800
+0.03
+(2.40%)
After hours: January 10 at 5:07:57 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
2,717.0000
462.0000
Operating Expense
51,790.0000
66,099.0000
63,451.0000
54,316.0000
17,006.0000
Operating Income
-51,790.0000
-66,099.0000
-63,451.0000
-51,599.0000
-16,544.0000
Net Non Operating Interest Income Expense
-3,127.0000
-1,784.0000
177.0000
-377.0000
-61.0000
Other Income Expense
--
--
--
-1,071.0000
-63.0000
Pretax Income
-54,917.0000
-67,883.0000
-63,274.0000
-53,047.0000
-16,668.0000
Tax Provision
--
--
70.0000
41.0000
35.0000
Net Income Common Stockholders
-28,169.0000
-33,970.0000
-30,588.0000
-8,331.0000
--
Diluted NI Available to Com Stockholders
-28,169.0000
-33,970.0000
-30,588.0000
-8,331.0000
--
Basic EPS
-1.05
-1.33
-1.28
-0.43
0.00
Diluted EPS
-1.05
-1.33
-1.28
-0.43
0.00
Basic Average Shares
26,773.2500
25,505.0000
23,817.0000
19,534.0000
18,738.6820
Diluted Average Shares
26,773.2500
25,505.0000
23,817.0000
19,534.0000
18,738.6820
Total Operating Income as Reported
-51,790.0000
-66,099.0000
-63,451.0000
-51,599.0000
-16,544.0000
Total Expenses
51,790.0000
66,099.0000
63,451.0000
54,316.0000
17,006.0000
Net Income from Continuing & Discontinued Operation
-28,169.0000
-33,970.0000
-30,588.0000
-8,331.0000
--
Normalized Income
-28,169.0000
-33,970.0000
-30,588.0000
-7,549.1700
45.9900
Interest Income
2,078.0000
3,301.0000
1,248.0000
89.0000
63.0000
Interest Expense
5,205.0000
5,085.0000
1,071.0000
466.0000
124.0000
Net Interest Income
-3,127.0000
-1,784.0000
177.0000
-377.0000
-61.0000
EBIT
-49,712.0000
-62,798.0000
-62,203.0000
-52,581.0000
-16,544.0000
EBITDA
-48,723.0000
-61,976.0000
-61,655.0000
-52,084.0000
-15,955.0000
Reconciled Depreciation
989.0000
822.0000
548.0000
497.0000
589.0000
Net Income from Continuing Operation Net Minority Interest
-28,169.0000
-33,970.0000
-30,588.0000
-8,331.0000
--
Total Unusual Items Excluding Goodwill
--
--
--
-1,071.0000
-63.0000
Total Unusual Items
--
--
--
-1,071.0000
-63.0000
Normalized EBITDA
-48,723.0000
-61,976.0000
-61,655.0000
-51,013.0000
-15,892.0000
Tax Rate for Calcs
--
--
0.0000
0.0003
0.0003
Tax Effect of Unusual Items
--
--
--
-289.1700
-17.0100
12/31/2020 - 7/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNYA Tenaya Therapeutics, Inc.
1.4600
+2.82%
VIRX Viracta Therapeutics, Inc.
0.1860
-0.91%
IOBT IO Biotech, Inc.
0.8710
+1.79%
GUTS Fractyl Health, Inc.
1.8500
-2.63%
OMGA Omega Therapeutics, Inc.
0.7060
-8.01%
INZY Inozyme Pharma, Inc.
1.9950
-28.75%
HOWL Werewolf Therapeutics, Inc.
1.3800
-4.17%
CLLS Cellectis S.A.
1.8500
-4.15%
OLMA Olema Pharmaceuticals, Inc.
5.04
-12.35%
TSHA Taysha Gene Therapies, Inc.
1.7600
-8.81%